146 related articles for article (PubMed ID: 8261749)
1. Alpha-glucosidase inhibition as an adjunct to the treatment of type 1 diabetes.
Tattersall R
Diabet Med; 1993 Oct; 10(8):688-93. PubMed ID: 8261749
[No Abstract] [Full Text] [Related]
2. Effect of alpha-inhibitors on blood glucose and insulin levels.
Laube H; Federlin K; Hillebrand I
Adv Exp Med Biol; 1988; 246():287-93. PubMed ID: 3074658
[No Abstract] [Full Text] [Related]
3. [Inhibitors of alpha-glucosidase].
Toeller M
Journ Annu Diabetol Hotel Dieu; 1991; ():203-12. PubMed ID: 1886331
[No Abstract] [Full Text] [Related]
4. Improving management of type 2 diabetes mellitus: 1. alpha-Glucosidase inhibitors.
Kuritzky L; Samraj G; Quillen DM
Hosp Pract (1995); 1999 Sep; 34(10):43-6. PubMed ID: 10901748
[No Abstract] [Full Text] [Related]
5. alpha-Glucosidase inhibition in the treatment of diabetes mellitus.
Dimitriadis G; Raptis S
Horm Metab Res Suppl; 1992; 26():42-9. PubMed ID: 1490691
[No Abstract] [Full Text] [Related]
6. Alpha-glucosidase inhibition and timing of preprandial insulin in patients with insulin-dependent diabetes mellitus (IDDM).
Kennedy FP; Gerich JE
Diabetes Res Clin Pract; 1988 Apr; 4(4):309-12. PubMed ID: 3286168
[TBL] [Abstract][Full Text] [Related]
7. The use of acarbose in the prevention and treatment of hypoglycaemia.
Lefebvre PJ; Scheen AJ
Eur J Clin Invest; 1994 Aug; 24 Suppl 3():40-4. PubMed ID: 8001627
[TBL] [Abstract][Full Text] [Related]
8. Effects of alpha-glucosidase inhibition on meal glucose tolerance and timing of insulin administration in patients with type I diabetes mellitus.
Dimitriadis G; Hatziagellaki E; Alexopoulos E; Kordonouri O; Komesidou V; Ganotakis M; Raptis S
Diabetes Care; 1991 May; 14(5):393-8. PubMed ID: 2060451
[TBL] [Abstract][Full Text] [Related]
9. The effect of miglitol and acarbose after an oral glucose load: a novel hypoglycaemic mechanism?
Joubert PH; Venter HL; Foukaridis GN
Br J Clin Pharmacol; 1990 Sep; 30(3):391-6. PubMed ID: 2223417
[TBL] [Abstract][Full Text] [Related]
10. Effect of alpha-glucosidase inhibition on glucose profiles in insulin dependent diabetes.
Hillman RJ; Scott M; Gray RS
Diabetes Res; 1989 Feb; 10(2):81-4. PubMed ID: 2663321
[TBL] [Abstract][Full Text] [Related]
11. An evaluation of the potential side-effects of alpha-glucosidase inhibitors used for the management of diabetes mellitus.
Reuser AJ; Wisselaar HA
Eur J Clin Invest; 1994 Aug; 24 Suppl 3():19-24. PubMed ID: 8001622
[TBL] [Abstract][Full Text] [Related]
12. Effect of miglitol and acarbose on starch digestion, daily plasma glucose profiles and cataract formation.
Madar Z; Hazan A
J Basic Clin Physiol Pharmacol; 1993; 4(1-2):69-81. PubMed ID: 8679512
[TBL] [Abstract][Full Text] [Related]
13. Alpha-glucosidase inhibitors for type 2 diabetes mellitus.
Van de Laar FA; Lucassen PL; Akkermans RP; Van de Lisdonk EH; Rutten GE; Van Weel C
Cochrane Database Syst Rev; 2005 Apr; 2005(2):CD003639. PubMed ID: 15846673
[TBL] [Abstract][Full Text] [Related]
14. Potential of alpha-glucosidase inhibitors in elderly patients with diabetes mellitus and impaired glucose tolerance.
Rabasa-Lhoret R; Chiasson JL
Drugs Aging; 1998 Aug; 13(2):131-43. PubMed ID: 9739502
[TBL] [Abstract][Full Text] [Related]
15. [Current status of the treatment of type 2 diabetes mellitus. Alpha-glucosidase inhibitors].
Blicklé JF; Andres E; Brogard JM
Rev Med Interne; 1999 Aug; 20 Suppl 3():379s-383s. PubMed ID: 10480189
[TBL] [Abstract][Full Text] [Related]
16. [Reducing postprandial glucose levels. Glucosidase antagonists].
Neye H
Pharm Unserer Zeit; 2002; 31(3):272-8. PubMed ID: 12071124
[No Abstract] [Full Text] [Related]
17. New horizons in diabetes therapy--alpha glucosidase inhibitors.
Jawad F
J Pak Med Assoc; 1994 Mar; 44(3):59-60. PubMed ID: 8040998
[No Abstract] [Full Text] [Related]
18. Potential pharmacokinetics interference between alpha-glucosidase inhibitors and other oral antidiabetic agents.
Scheen AJ; Lefèbvre PJ
Diabetes Care; 2002 Jan; 25(1):247-8. PubMed ID: 11772929
[No Abstract] [Full Text] [Related]
19. [Pharmacokinetic, pharmacological, and clinical profile of miglitol (SEIBULE), a novel alpha-glucosidase inhibitor].
Kuboyama N; Hayashi I; Yamaguchi T
Nihon Yakurigaku Zasshi; 2006 Mar; 127(3):223-32. PubMed ID: 16651808
[No Abstract] [Full Text] [Related]
20. [Miglitol in the treatment of the insulin-dependent diabetic patient. Improved metabolic control and excellent tolerance].
Rinninger F; Lotz N; Hillebrand I; Bachmann W
Fortschr Med; 1987 Jul; 105(22):435-8. PubMed ID: 3653827
[No Abstract] [Full Text] [Related]
[Next] [New Search]